The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
within the community of people that use bpc157 for therapeutic reasons for tissue Rejuvenation and repair there's sort of been an ongoing debate as to whether or not you can take it systemically that is to inject it or even take it orally and that it will find the sight of injury right it'll go direct itself to the S side of injury or whether or not it's more beneficial to inject it directly to the site of injury
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
meaning that many many people perhaps even most people who take bpc 157 by the way the typical route of taking bpc 157 is either to inject it subcutaneously or into the muscle and to do that regardless of where the injury is they'll do that in one particular site so subcutaneously just a few inches off the belly button or into um you know into the shoulder or something of that sort if they're doing it intramuscularly
now this Still Remains somewhat of a mystery it is clear that bpc 157 can exit the gut but how it gets traffic to particular sites within the body that are injured still isn't clear
It seems, at least the last I heard, that you don't need to do that.